LNSR missed EPS expectations by 162.55%
Aug 08, 2024, 12:32 PM
0.00%
What does LNSR do
LENSAR, Inc., headquartered in Orlando, Florida with 110 employees, specializes in femtosecond laser technology for refractive cataract surgery, launching its IPO in 2020. The company offers the LENSAR Laser System and the ALLY Adaptive Cataract Treatment System, enhancing surgical outcomes with proprietary technologies.
LENSAR (LNSR) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, LENSAR's actual EPS was -$0.79, missing the estimate of -$0.30 per share, resulting in a -162.55% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.